Bayesian Capital Management’s Zions Bancorporation ZION Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,338
Closed -$216K 919
2025
Q1
$216K Sell
4,338
-13,700
-76% -$738K 0.04% 474
2024
Q4
$979K Buy
+18,038
New +$988K 0.12% 232
2024
Q2
Sell
-28,200
Closed -$1.22M 1152
2024
Q1
$1.22M Buy
+28,200
New +$1.16M 0.12% 246
2023
Q4
Sell
-60,800
Closed -$2.12M 1072
2023
Q3
$2.12M Buy
60,800
+1,500
+3% +$52.3K 0.24% 106
2023
Q2
$1.59M Buy
59,300
+50,515
+575% +$1.4M 0.17% 165
2023
Q1
$263K Buy
+8,785
New +$402K 0.03% 546
2021
Q3
Sell
-8,653
Closed -$457K 582
2021
Q2
$457K Buy
8,653
+1,853
+27% +$104K 0.12% 205
2021
Q1
$374K Buy
+6,800
New +$350K 0.09% 299
2020
Q2
Sell
-27,661
Closed -$740K 835
2020
Q1
$740K Buy
+27,661
New +$1.14M 0.16% 193
2019
Q2
Sell
-39,900
Closed -$1.81M 697
2019
Q1
$1.81M Buy
+39,900
New +$1.9M 0.35% 84
2018
Q4
Sell
-9,399
Closed -$471K 818
2018
Q3
$471K Buy
9,399
+2,170
+30% +$115K 0.08% 348
2018
Q2
$381K Buy
+7,229
New +$399K 0.09% 336

Other funds holding ZION

Bayesian Capital Management's ZION Position: Q2 2025 in Review

Bayesian Capital Management sold out of Zions Bancorporation (ZION) in Q2 2025, closing a stake of 4,338 shares — an estimated $216K sold.

Bayesian Capital Management first reported a position in ZION in Q2 2018 and held it in 12 quarters. The position peaked at $2.12M in Q3 2023. 492 funds tracked by Wall St. Rank hold ZION as of Q2 2025.

  • Bayesian Capital Management reported no remaining Zions Bancorporation position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 4,338 Zions Bancorporation shares in Q2 2025, an estimated $216K.
  • Bayesian Capital Management first reported a position in Zions Bancorporation in Q2 2018 and held it in 12 quarters.
  • Bayesian Capital Management's Zions Bancorporation position peaked at $2.12M in Q3 2023.
  • 492 funds tracked by Wall St. Rank held Zions Bancorporation as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.